MDRX News and Press, Allscripts Healthcare Solutions Inc. From 12/04/23

SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 26, 2021 – June 13, 2023 Lead Plaintiff Deadline: Jan. 22, 2024 Visit: ...

Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Veradigm securities between February 26, 2021 and...

Veradigm Inc. (MDRX) is expected to report $0.17 for Q3 2023 Aperam SA New York Shares (APEMY) is expected to report for Q3 2023 HTG Molecular Diagnostics Inc. (HTGMQ) is expected to report for Q3 2023 Enel Spa ADR (ENLAY) is expected to report for Q3 2023 Firm Capital Property Tr...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MDRX Investors with Substantial Losses to Contact Firm San Francisco, California--(Newsfile Corp. - November 29, 2023) - Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX) investors who suffered substantial losses to submit your losses now . ...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Veradigm To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Veradigm between February 26, 2021 and June 13, 2023 and would like to discuss your legal rights, c...

SAN FRANCISCO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 26, 2021 – June 13, 2023 Lead Plaintiff Deadline: Jan. 22, 2024 Visit: ...

Boston, Massachusetts--(Newsfile Corp. - November 27, 2023) - A class action lawsuit has been filed against Veradigm, Inc. (NASDAQ: MDRX) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm  to learn more about how they might ...

Philadelphia, Pennsylvania--(Newsfile Corp. - November 27, 2023) - Current Veradigm, Inc. (NASDAQ: MDRX) shareholders who have held shares of the Company's stock since at least February 26, 2021, have standing to seek corporate reforms, the return of funds back to company coffers and potentially ...

Impac Mortgage Holdings, Inc. (IMPM) is expected to report for quarter end 2023-09-30 Westbury Bancorp Inc (WBBW) is expected to report for quarter end 2023-09-30 Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.24 for Q3 2023 Zalando SE ADR (ZLNDY) is expected to report for...

2023-11-20 06:53:07 ET Veradigm ( NASDAQ: MDRX ) received notice from Nasdaq that the Company remains noncompliant with timely filing of all periodic reports because the Company has not filed its Annual Report on Form 10-K for 2022, Q1, Q2, and Q3 10-Q. On October 6, 2023...